DK3752141T3 - Acetyl-leucin til anvendelse til behandling af restless legs syndrom - Google Patents
Acetyl-leucin til anvendelse til behandling af restless legs syndrom Download PDFInfo
- Publication number
- DK3752141T3 DK3752141T3 DK19710788.1T DK19710788T DK3752141T3 DK 3752141 T3 DK3752141 T3 DK 3752141T3 DK 19710788 T DK19710788 T DK 19710788T DK 3752141 T3 DK3752141 T3 DK 3752141T3
- Authority
- DK
- Denmark
- Prior art keywords
- leucine
- acetyl
- treatment
- restless legs
- legs syndrome
- Prior art date
Links
- WXNXCEHXYPACJF-ZETCQYMHSA-N N-acetyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(C)=O WXNXCEHXYPACJF-ZETCQYMHSA-N 0.000 title 1
- 208000005793 Restless legs syndrome Diseases 0.000 title 1
- 229960000669 acetylleucine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862631383P | 2018-02-15 | 2018-02-15 | |
| PCT/IB2019/051214 WO2019159110A1 (en) | 2018-02-15 | 2019-02-14 | Therapeutic agents for treating restless legs syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3752141T3 true DK3752141T3 (da) | 2024-07-15 |
Family
ID=65763687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19710788.1T DK3752141T3 (da) | 2018-02-15 | 2019-02-14 | Acetyl-leucin til anvendelse til behandling af restless legs syndrom |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US11660279B2 (da) |
| EP (1) | EP3752141B1 (da) |
| JP (1) | JP7337081B2 (da) |
| KR (1) | KR102693607B1 (da) |
| CN (1) | CN111712239A (da) |
| AU (1) | AU2019221886B2 (da) |
| BR (1) | BR112020016672A2 (da) |
| CA (1) | CA3091353A1 (da) |
| DK (1) | DK3752141T3 (da) |
| ES (1) | ES2983441T3 (da) |
| FI (1) | FI3752141T3 (da) |
| HR (1) | HRP20240925T1 (da) |
| HU (1) | HUE067240T2 (da) |
| IL (1) | IL276576B2 (da) |
| LT (1) | LT3752141T (da) |
| MA (1) | MA51836B1 (da) |
| MD (1) | MD3752141T2 (da) |
| MX (1) | MX2020008504A (da) |
| PL (1) | PL3752141T3 (da) |
| PT (1) | PT3752141T (da) |
| RS (1) | RS65663B1 (da) |
| SG (1) | SG11202007721YA (da) |
| SI (1) | SI3752141T1 (da) |
| SM (1) | SMT202400281T1 (da) |
| WO (1) | WO2019159110A1 (da) |
| ZA (1) | ZA202004849B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201709459D0 (en) | 2017-06-14 | 2017-07-26 | Intrabio Ltd | Treatment for migraine |
| US12145899B2 (en) | 2018-12-06 | 2024-11-19 | Intrabio Ltd. | Deuterated analogs of acetyl-leucine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2377234C2 (ru) | 2003-09-17 | 2009-12-27 | Ксенопорт, Инк. | Лечение или предупреждение синдрома беспокойных ног с использованием пролекарств аналогов гамк |
| EP1677812A4 (en) | 2003-09-17 | 2010-03-24 | Xenoport Inc | TREATMENT OR PREVENTION OF NON-REST LEG SYNDROME USING GABA ANALOGUE-BASED PRODRUGS |
| US8946300B2 (en) * | 2006-04-03 | 2015-02-03 | Teva Pharmaceutical Industries, Ltd. | Use of rasagilline for the treatment of restless legs syndrome |
| TN2010000251A1 (fr) * | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| SMT201600385T1 (it) | 2010-06-25 | 2017-03-08 | Shire Human Genetic Therapies | Trasporto di agenti terapeutici all’snc |
| JPWO2015129527A1 (ja) | 2014-02-27 | 2017-03-30 | 株式会社 メドレックス | プラミペキソールを含有する神経変性疾患の治療用貼付剤 |
| CN109789114A (zh) | 2016-08-11 | 2019-05-21 | 内在生物技术有限公司 | 神经退行性疾病的治疗剂 |
| GB201709459D0 (en) | 2017-06-14 | 2017-07-26 | Intrabio Ltd | Treatment for migraine |
| CA3079194A1 (en) | 2017-10-18 | 2019-04-25 | Intrabio Limited | Therapeutic agents for neurodegenerative diseases |
-
2019
- 2019-02-14 FI FIEP19710788.1T patent/FI3752141T3/fi active
- 2019-02-14 EP EP19710788.1A patent/EP3752141B1/en active Active
- 2019-02-14 WO PCT/IB2019/051214 patent/WO2019159110A1/en not_active Ceased
- 2019-02-14 IL IL276576A patent/IL276576B2/en unknown
- 2019-02-14 HU HUE19710788A patent/HUE067240T2/hu unknown
- 2019-02-14 MA MA51836A patent/MA51836B1/fr unknown
- 2019-02-14 SI SI201930784T patent/SI3752141T1/sl unknown
- 2019-02-14 LT LTEPPCT/IB2019/051214T patent/LT3752141T/lt unknown
- 2019-02-14 BR BR112020016672-3A patent/BR112020016672A2/pt unknown
- 2019-02-14 JP JP2020543526A patent/JP7337081B2/ja active Active
- 2019-02-14 PL PL19710788.1T patent/PL3752141T3/pl unknown
- 2019-02-14 HR HRP20240925TT patent/HRP20240925T1/hr unknown
- 2019-02-14 DK DK19710788.1T patent/DK3752141T3/da active
- 2019-02-14 SG SG11202007721YA patent/SG11202007721YA/en unknown
- 2019-02-14 CN CN201980013046.8A patent/CN111712239A/zh active Pending
- 2019-02-14 MD MDE20201273T patent/MD3752141T2/ro unknown
- 2019-02-14 SM SM20240281T patent/SMT202400281T1/it unknown
- 2019-02-14 KR KR1020207025231A patent/KR102693607B1/ko active Active
- 2019-02-14 MX MX2020008504A patent/MX2020008504A/es unknown
- 2019-02-14 AU AU2019221886A patent/AU2019221886B2/en active Active
- 2019-02-14 RS RS20240709A patent/RS65663B1/sr unknown
- 2019-02-14 CA CA3091353A patent/CA3091353A1/en active Pending
- 2019-02-14 PT PT197107881T patent/PT3752141T/pt unknown
- 2019-02-14 ES ES19710788T patent/ES2983441T3/es active Active
- 2019-02-14 US US16/968,919 patent/US11660279B2/en active Active
-
2020
- 2020-08-05 ZA ZA2020/04849A patent/ZA202004849B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3227675T3 (da) | Activin-actrii-antagonister og anvendelser til behandling af myelodysplastisk syndrom | |
| DK3490582T3 (da) | Sammensætninger til anvendelse i behandling af myelofibrose | |
| DK3888641T3 (da) | Anvendelse af cannabidiol i behandling af anfald i forbindelse med doose-syndrom | |
| DK3570940T3 (da) | Pridopidin til anvendelse i behandling af fragilt x-syndrom | |
| DK3325509T3 (da) | Anti-tfr antistoffer og deres anvendelse i behandling af proliferative og inflammatoriske lidelser | |
| DK3504187T3 (da) | Anvendelse af pridopidin til behandling af funktionel tilbagegang | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3307296T3 (da) | Timp2 til anvendelse til behandling af aldringsassocierede tilstande | |
| DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
| DK3512506T3 (da) | Anvendelse af pridopidin til behandling af retts syndrom | |
| DK3978074T3 (da) | Terlipressin til behandling af hepatorenalt syndrom type 1 | |
| DK3302519T3 (da) | Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom | |
| DK3236960T3 (da) | Fluralaner til anvendelse i behandling af demodicose | |
| DK3706739T3 (da) | Anvendelse af riluzolprodrugs til behandling af ataksier | |
| DK3666258T3 (da) | Fremgangsmåde til behandling af prader-willis syndrom | |
| HUE057257T2 (hu) | Folyékony készítmény gyomor- és nyelõcsõ reflux kezelésében történõ alkalmazásra | |
| DK3188727T3 (da) | Tasimelteon til behandling af smith-magenis¿ syndrom | |
| DK3402474T3 (da) | Il-8-inhibitorer til anvendelse i behandlingen af kemoterapi-induceret perifer neuropati | |
| DK3866799T3 (da) | Sammensætninger til behandling af vaskulært ehlers-danlos syndrom | |
| EP3812208A4 (en) | Rocking cart table | |
| DK3442558T3 (da) | Bmp-7-afledte peptider til anvendelse i behandlingen af osteoartritis | |
| DK3373922T3 (da) | Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri | |
| DK3229827T3 (da) | Modificerede peptider og anvendelse deraf til behandling af kroniske inflammatoriske sygdomme | |
| DK3752141T3 (da) | Acetyl-leucin til anvendelse til behandling af restless legs syndrom |